Loading ...

Michele DesMarais

Immune Tolerance Network

Associate Director, Clinical Operations Clinical Trials Group

http://www.immunetolerance.org

Assessment Group

mdesmarais@immunetolerance.org

Work:

415-353-4406

Mobile:

415-420-4250

Address:

Immune Tolerance Network

Committees:

,

Studies:

ITN010ST

-

Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow Transplant

ITN023ST

-

Belatacept to Prevent Organ Rejection in Kidney Transplant Patients

ITN036ST

-

Renal Allograft Tolerance through Mixed Chimerism

ITN524ST-CTOT-12

-

Associating Renal Transplantation With the ITN Signature of Tolerance

ITN024ST

-

Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients

ITN029ST

-

Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients

ITN030ST

-

Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant

ITN039ST

-

Research Study of ATG and Rituximab in Renal Transplantation

ITN040CT

-

Immunosuppressive Medications for Participants in ITN005CT

ITN507ST

-

Study of Tolerant Kidney Transplant Recipients

ITN054ST

-

BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance

ITN056ST

-

Evaluation of Donor Specific Immune Senescence and Exhaustion as Biomarkers of Tolerance Post Liver Transplantation

ITN063ST

-

A Cohort Study of Operationally Tolerant Allograft Recipients

ITN062ST

-

Tolerance by engaging antigen during cellular homeostasis

ITN069ST

-

Renal Allograft Tolerance Through Mixed Chimerism And Co-Stimulation Blockade With Belatacept

ITN823ST

-

Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients

ITN082AD

-

Atopic Dermatitis Dupilumab and anti-OX40 Treatment for Sustained Efficacy

Bio:

Admin Links

Shortcuts

ITN Documents

Links